Note: For this episode, because we are discussing the narrative capabilities of AI, I asked ChatGPT to write a summary based on the transcript of our conversation. I enjoy doing these interviews and consider myself a decent writer. However, it takes a lot of time each week to write a summary that I find minimally satisfying and acceptable. You deserve better and I can put my efforts to better use elsewhere or upgrading the whole experience here. I did lightly edit this to make it sound as if I could have written it. Let me know what you think in the comments.
In this episode, I had the opportunity to chat with Matt Lewis, the Chief AI Officer at Inizio Medical. We dove into the world of artificial intelligence (AI) and its pivotal role in the field of medical affairs, particularly in aiding the commercialization of medical innovations. This conversation shed light on the remarkable ways in which AI can be harnessed to enhance decision-making, streamline data analysis, and shape the narratives around product launches.
Introduction
Inizio supports various players in the life sciences arena, including pharmaceuticals, biotechnology, medical devices, digital therapeutics, and more. Inizio helps these entities translate their scientific endeavors into compelling narratives tailored for a diverse set of stakeholders, from clinicians to regulators, payers, and patients.
AI has been a significant player in the medical field for several years. Matt, with over a decade of experience in medical affairs and 15 years in AI, highlighted how AI first emerged as a solution to address the overwhelming volume of scientific data, including clinical research, published papers, and patient information. This surge in data presented a challenge as it exceeded the capacity of an individual to process effectively.
Matt went on to explain how AI, particularly Natural Language Processing (NLP), was employed to sift through vast amounts of content. This enabled the identification of relevant terms and concepts that were crucial for strategists and scientists to focus on. It essentially acted as a tool for surfacing meaningful insights from the sea of information. The AI-driven lexicon analysis and scientific platform considerations played a vital role in ensuring that medical professionals could efficiently navigate the complex landscape of scientific data.
The Role of Subject Matter Expertise in AI
While AI is a powerful tool, it requires substantial input from subject matter experts. To effectively utilize AI, you need to define the key terms and concepts that the tool should focus on. In the medical field, this entails understanding the therapeutic area, specific indications, and relevant terms and vocabulary that are integral to the domain. Without this critical input, AI can't effectively sift through and categorize the data. It should be viewed as an amplifier of human expertise rather than a replacement for it.
Crafting Effective Narratives with AI
How can AI be used to craft narratives that resonate with various audiences? Matt explained that in the past, narrative development was often based on subjective, qualitative discussions within multidisciplinary groups. While these discussions were essential, they sometimes lacked objectivity. The loudest voices or the strongest opinions often win.
There was a lot of evidence, but sometimes the subjectivity and the qualitative nature of kind of what made sense of the organization kind of won the day, if you will. I think when we started moving into more of an evidence-centric, data-centric, AI-centric type of environment, those contributions are still there for sure, but they're kind of counterbalanced by more of an objective evidence-based approach…
AI has transformed this process by providing an evidence-centric, data-driven approach. Instead of relying solely on subjective opinions, AI can analyze data to reveal how different narratives perform in the market. For example, if several competitors dominate a specific narrative, it might not be the best strategy to enter that conversation. AI can help identify unexplored "blue ocean" areas where the competition is less intense.
Matt also highlighted that AI has evolved to provide real-time insights based on citation information, sentiment data, and relevant word associations. This dynamic approach allows companies to adjust their narratives based on changing market conditions and emerging trends. The ability to capture contextual intelligence from medical encounters, such as conversations between medical science liaisons and opinion leaders, provides valuable insights for crafting narratives. AI's role is not to replace human input but to augment it and ensure that strategic decisions are grounded in data-driven insights.
Either way, I appreciate you spending time here.
AI and Drug Repurposing
AI is also playing a vital role in drug repurposing. AI can help identify existing drugs that have the potential to be repurposed for new therapeutic uses. By analyzing vast amounts of scientific data, AI can uncover hidden connections and suggest novel applications for existing drugs. This approach not only accelerates the drug discovery process but also helps in finding treatments for conditions that were previously overlooked. The ability to sift through extensive literature and uncover these hidden gems is a game-changer for the pharmaceutical industry.
The Data Sources for Insights
Conversations between medical science liaisons and key opinion leaders are a primary source of the data used. These conversations are crucial for understanding the sentiments, opinions, and insights of experts in the field. Additional data sources include advisory board meetings, market research, and physician interactions with medical information customer centers.
Currently, conversations are not typically recorded due to privacy and legal considerations. The information is likely captured in field notes, which are then input into Customer Relationship Management (CRM) systems. AI is used to analyze this data and extract insights, but the human touch remains essential in filtering and interpreting the information.
The Future of AI in Medical Affairs
There is the potential for AI to capture not only the words spoken but also the tone and emotional cues in conversations. AI could help detect subtle nuances in conversations, allowing for a deeper understanding of sentiment. This level of emotional intelligence could be a valuable tool for improving customer interactions.
The integration of AI in CRM systems is also expected to grow, providing more robust insights and streamlining the entire process. With advancements in technology and an increasing comfort with AI in the medical and scientific community, we may see a shift toward recorded conversations, enabling more comprehensive and context-rich analysis of customer interactions.
Conclusion
AI, when combined with human expertise, has the potential to revolutionize the way medical professionals navigate the sea of data and make informed, data-driven decisions. The future promises even greater integration of AI, enhancing the quality and depth of insights, and ultimately improving the medical and scientific landscape.
Your deepest insights are your best branding. I’d love to help you share them. Chat with me about custom content for your life science brand. Or visit my website.
Share this post